4.7 Article

BCL11B Regulates Arterial Stiffness and Related Target Organ Damage

Journal

CIRCULATION RESEARCH
Volume 128, Issue 6, Pages 755-768

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCRESAHA.120.316666

Keywords

actins; blood pressure; calcineurin; phosphorylation; vascular smooth muscle; vascular stiffness

Funding

  1. National Institutes of Health [HL136311, HL105287, AG053274, AG050599, HL136224, AI067846]
  2. National Heart, Lung, and Blood Institute's Framingham Heart Study [N01HC-25195, HHSN268201500001I, HL070100, HL080124, HL107385, HL126136]
  3. NIH [HL007224]
  4. pilot grants [1UL1TR001430, 5P30DK046200]
  5. Evans Center for Interdisciplinary Biomedical Research Arterial Stiffness ARC at Boston University

Ask authors/readers for more resources

The study reveals that BCL11B is expressed in vascular smooth muscle and regulates vascular stiffness. RNA sequencing in Bcl11b null mice identified changes in signaling pathways leading to increased arterial stiffness and cardiovascular damage.
Rationale: BCL11B (B-cell leukemia 11b) is a transcription factor known as an essential regulator of T lymphocytes and neuronal development during embryogenesis. A genome-wide association study showed that a gene desert region downstream of BCL11B, known to function as a BCL11B enhancer, harbors single nucleotide polymorphisms associated with increased arterial stiffness. However, a role for BCL11B in the adult cardiovascular system is unknown. Objective: Based on these human findings, we sought to examine the relation between BCL11B and arterial function. Methods and Results: Here we report that BCL11B is expressed in the vascular smooth muscle where it regulates vascular stiffness. RNA sequencing of aortas from wild-type and Bcl11b null mice (BSMKO) identified the cGMP (cyclic guanosine monophosphate)-cGMP-dependent protein kinase G (PKG) as the most significant differentially regulated signaling pathway in BSMKO compared with wild-type mice. BSMKO aortas showed decreased levels of PKG1, increased levels of Ca++-calmodulin-dependent serine/threonine phosphatase calcineurin (PP2B) and decreased levels of their common phosphorylation target, phosphorylated vasodilator-stimulated phosphoprotein (pVASP(S239)), a regulator of cytoskelatal actin rearrangements. Decreased pVASP(S239) in BSMKO aortas was associated with increased actin polymerization (filamentous/globular actin ratio). Functionally, aortic force, stress, wall tension, and stiffness, measured ex vivo in organ baths, were increased in BSMKO aortas, and BSMKO mice had increased pulse wave velocity, the in vivo index of arterial stiffness. Despite having no effect on blood pressure or microalbuminuria, increased arterial stiffness in BSMKO mice was associated with increased incidence of cerebral microbleeds compared with age-matched wild-type littermates. Conclusions: We have identified vascular smooth muscle BCL11B as a crucial regulator of aortic smooth muscle function and a potential therapeutic target for vascular stiffness.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available